Some concerns about prostate cancer location, gleason grade, and postradiation doubling times
Open Access
- 1 November 1995
- journal article
- editorial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 33 (4) , 967-968
- https://doi.org/10.1016/0360-3016(95)02145-6
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- The treatment of prostate cancer by conventional radiation therapy: An analysis of long-term outcomeInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Making the most out of six systematic sextant biopsiesUrology, 1995
- The Value of Serial Prostate Specific Antigen Determinations 5 Years after Radiotherapy: Steeply Increasing Values Characterize 80% of PatientsJournal of Urology, 1993
- Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volumeCancer, 1993
- The Predictive Significance of Substaging Stage A Prostate Cancer (A1 Versus A2) for Volume and Grade of Total Cancer in the ProstateJournal of Urology, 1992
- Cancer volume and site of origin of adenocarcinoma in the prostate: Relationship to local and distant spreadHuman Pathology, 1992
- Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostateCancer, 1990
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radiation Treated PatientsJournal of Urology, 1989